At Sunac Therapeutics, we believe patients deserve more than pain relief — they deserve restoration.
Our mission is to develop the first therapy that truly reverses osteoarthritis and degenerative disc disease (DDD) by targeting the root cause: cellular senescence
Sunac is a first-in-class, single-dose regenerative therapy that restores cellular health and function.
Starting with degenerative disc disease, we’re building a pipeline to treat all major OA joints, with a clear path to clinical readiness
Sunac is a seed-stage biotech built by experienced business leaders taking companies to exits and physicians and scientists in orthopedics, regenerative medicine, , engineering, and molecular biology.
Our focus: a first-in-class regenerative therapy for osteoarthritis and degenerative disc disease.
Copyright © 2025 Sunac - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.